Echo Therapeutics, Inc. Press Releases

ECTE 
$1.5416
*  
0.0416
2.77%
Get ECTE Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading ECTE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer
12/23/2014 8:36:00 AM - PR Newswire
▼-1.18 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Echo Therapeutics Announces Third Quarter 2014 Financial Results
11/19/2014 6:00:00 PM - PR Newswire


Echo Therapeutics to Present Positive Clinical Trial Results at the 14th Annual Diabetes Technology Meeting
11/3/2014 7:50:00 AM - PR Newswire
▲180.29 % Price Change since this news event. The Volume Ratio is 5.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Platinum Comments On Recent Statements Purportedly Made By Echo Therapeutics
10/6/2014 9:26:00 AM - PR Newswire


Echo Therapeutics Comments On Special Meeting Proxy Contest Threatened By Platinum Management (NY) LLC
10/6/2014 9:10:00 AM - PR Newswire


Echo Therapeutics Engages PricewaterhouseCoopers'' Restructuring Practice to Explore Financial and Strategic Alternatives
10/2/2014 4:59:00 PM - PR Newswire


Echo Therapeutics Engages PricewaterhouseCoopers' Restructuring Practice to Explore Financial and Strategic Alternatives
10/2/2014 4:59:00 PM - PR Newswire


Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg
10/2/2014 7:50:00 AM - PR Newswire


Platinum Management (NY) LLC Calls for a Special Meeting of Stockholders at Echo Therapeutics, Inc.
9/29/2014 3:49:00 PM - PR Newswire